Aroda, Vanita R. http://orcid.org/0000-0002-7706-4585
Blonde, Lawrence http://orcid.org/0000-0003-0492-6698
Pratley, Richard E. http://orcid.org/0000-0002-2912-1389
Funding for this research was provided by:
Novo Nordisk Inc
Article History
Accepted: 19 April 2022
First Online: 15 July 2022
Declarations
:
: N/A.
: N/A.
: N/A.
: N/A.
: VRA has served as a consultant for Applied Therapeutics, Fractyl Health, Novo Nordisk, Pfizer, and Sanofi; VRA’s spouse is employed by Janssen Pharmaceuticals, Inc. and receives employment benefits; VRA has received institutional contracts for research from Applied Therapeutics, Eli Lilly, Fractyl Health, Novo Nordisk, and Sanofi. LB has received consultancy fees from Corcept Therapeutics, Gilead, Janssen Pharmaceuticals, Inc., Lyndra Therapeutics, Merck, Novo Nordisk, Salix Pharmaceuticals, and Sanofi; and has received speaker fees from Sanofi. REP reports consulting fees from Bayer AG, Corcept Therapeutics, Dexcom, Hanmi Pharmaceutical Co., Merck, Novo Nordisk, Pfizer, Sanofi, Scohia Pharma Inc., and Sun Pharmaceutical Industries; and grants/research support from Hanmi Pharmaceutical Co., Janssen Pharmaceuticals, Inc., Metavention, Novo Nordisk, Poxel SA, and Sanofi. All funds are paid directly to Dr. Pratley’s employer, AdventHealth, a nonprofit organization that supports education and research.